Cellectar Biosciences Financial Overview
Cellectar Biosciences's market cap is currently $11.36M. The company's EPS TTM is $-1.41; its P/E ratio is -0.27; Cellectar Biosciences is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-1.22. See an overview of income statement, balance sheet, and cash flow financials.
